外围内皮功能对主要心血管不良事件的预后值高于传统风险因素
Nazanin Rajai1, Takumi Toya1,2, Jaskanwal D Sara1
1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA.
European journal of preventive cardiology
|July 11, 2023
概括
周围微血管功能障碍 (PMED) 独立预测主要不良心血管事件 (MACE). 非侵入性地评估内皮功能可以改善高风险患者的心血管风险分层.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 已确定的心血管风险得分可能无法完全捕捉个体患者的风险.
- 周围微血管功能障碍 (PMED) 是动脉样硬化的新兴标志物.
- 早期发现内皮功能障碍对于预测心血管事件至关重要.
研究的目的:
- 为了确定是否将PMED添加到现有的风险得分中,可以改善预测主要不良心血管事件 (MACE) 的情况.
- 为了评估MACE的反应性高血压指数 (RHI) 的预后值.
- 评估PMED作为心血管事件的独立预测因素.
主要方法:
- 对1460名患者 (2006-2020年) 进行外周动脉度测试的回顾性分析.
- 为MACE预测计算的最佳反应性高血压指数 (RHI) 截止值.
- 使用传统因素 (CHA2DS2-Vasc,Framingham) 进行MACE风险比较,使用和不使用PMED.
主要成果:
- 确定了最佳的RHI切断点 (总体为1.83,根据性别有所不同).
- 周围微血管功能障碍 (PMED) 与明显更差的无MACE生存率相关 (P < 0.001).
- 多变量分析证实PMED是MACE的独立预测因子,即使经过对传统风险因素和得分进行调整.
结论:
- 周围微血管功能障碍 (PMED) 是主要心血管不良事件 (MACE) 的重要独立预测因素.
- 与RHI一样,对外围内皮功能进行非侵入性评估有助于早期检测.
- 纳入PMED评估可以提高高风险个体的心血管风险分层.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Peripheral Artery Disease I: Introduction
10
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
10
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
121
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
121
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11


